Work

T Cells Expressing a Novel Fully-Human Anti-CD19 Chimeric Antigen Receptor Induce Remissions of Advanced Lymphoma in a First-in-Humans Clinical Trial

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.999.999

Authors: Jennifer N. Brudno, Victoria Shi, David Stroncek, Stefania Pittaluga, Jennifer A. Kanakry, Lauren M. Curtis, Juan C. Gea-Banacloche, Steven Pavletic, Mohammad-Hadi Bagheri, Jeremy J. Rose, Rashmika Patel, Brenna Hansen, Ronald E. Gress, James N. Kochenderfer

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, National Institutes of Health Clinical Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590810691

FWCI: 2.635

Cites:

Cited by: 30

Related to: 10